Literature DB >> 20013236

Generation of gene-specific mutated rats using zinc-finger nucleases.

Aron M Geurts1, Gregory J Cost, Séverine Rémy, Xiaoxia Cui, Laurent Tesson, Claire Usal, Séverine Ménoret, Howard J Jacob, Ignacio Anegon, Roland Buelow.   

Abstract

The genetic dissection of physiological and pathological traits in laboratory model organisms is accelerated by the ability to engineer loss-of-function mutations at investigator-specified loci. This chapter describes the use of zinc-finger nucleases (ZFNs) for the targeted disruption of endogenous rat genes directly in the embryo. ZFNs can specifically disrupt target genes in cultured rat cells and in embryos from inbred and outbred strains, leading to permanently genetically modified animals. This technology allows for the rapid, targeted modification of the rat genome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20013236     DOI: 10.1007/978-1-60327-389-3_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  69 in total

Review 1.  Candidate genes for hypertension: insights from the Dahl S rat.

Authors:  Nathan P Rudemiller; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-15

2.  Lung injury pathways: Adenosine receptor 2B signaling limits development of ischemic bronchiolitis obliterans organizing pneumonia.

Authors:  John C Densmore; Terry R Schaid; Paul M Jeziorczak; Meetha Medhora; Said Audi; Shraddha Nayak; John Auchampach; Melinda R Dwinell; Aron M Geurts; Elizabeth R Jacobs
Journal:  Exp Lung Res       Date:  2017-03-07       Impact factor: 2.459

Review 3.  Gene-edited CRISPy Critters for alcohol research.

Authors:  Gregg E Homanics
Journal:  Alcohol       Date:  2018-03-07       Impact factor: 2.405

Review 4.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

5.  "Transgenesis, recent technical developments and applications" Nantes, 8th June 2009.

Authors:  Séverine Ménoret; Laurent Tesson; Séverine Remy; Claire Usal; Anne-Laure Iscache; Ignacio Anegon
Journal:  Transgenic Res       Date:  2009-11-01       Impact factor: 2.788

6.  p66Shc regulates renal vascular tone in hypertension-induced nephropathy.

Authors:  Bradley Miller; Oleg Palygin; Victoriya A Rufanova; Andrew Chong; Jozef Lazar; Howard J Jacob; David Mattson; Richard J Roman; Jan M Williams; Allen W Cowley; Aron M Geurts; Alexander Staruschenko; John D Imig; Andrey Sorokin
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

7.  Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.

Authors:  Shraddha Nayak; Md Abdul H Khan; Tina C Wan; Hong Pei; Joel Linden; Melinda R Dwinell; Aron M Geurts; John D Imig; John A Auchampach
Journal:  Purinergic Signal       Date:  2015-09-18       Impact factor: 3.765

Review 8.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

9.  Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.

Authors:  Chun Cheng Andy Chen; Aron M Geurts; Howard J Jacob; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2012-12-18       Impact factor: 3.107

10.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.